Found: 18
Select item for more details and to access through your institution.
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis.
- Published in:
- European Journal of Neurology, 2016, v. 23, n. 4, p. 729, doi. 10.1111/ene.12929
- By:
- Publication type:
- Article
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 6, p. 981, doi. 10.1111/ene.12696
- By:
- Publication type:
- Article
Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
- Published in:
- European Journal of Neurology, 2013, v. 20, n. 6, p. 907, doi. 10.1111/ene.12087
- By:
- Publication type:
- Article
Baseline brain activity changes in patients with clinically isolated syndrome revealed by resting-state functional MRI.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 4, p. 1, doi. 10.1177/2055217318815513
- By:
- Publication type:
- Article
Brief Communication Cladribine followed by autologous stem-cell transplantation in progressive multiple sclerosis.
- Published in:
- Internal Medicine Journal, 2004, v. 34, n. 1/2, p. 66, doi. 10.1111/j.1444-0903.2004.00516.x
- By:
- Publication type:
- Article
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2006, v. 12, n. 6, p. 769, doi. 10.1177/1352458506070775
- By:
- Publication type:
- Article
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability.
- Published in:
- Multiple Sclerosis (13524585), 2006, v. 12, n. 5, p. 620, doi. 10.1177/1352458506070658
- By:
- Publication type:
- Article
Amine oxidase activity of β-amyloid precursor protein modulates systemic and local catecholamine levels.
- Published in:
- Molecular Psychiatry, 2013, v. 18, n. 2, p. 245, doi. 10.1038/mp.2011.168
- By:
- Publication type:
- Article
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
- Published in:
- Genes & Immunity, 2008, v. 9, n. 7, p. 624, doi. 10.1038/gene.2008.59
- By:
- Publication type:
- Article
The occurrence of dystonia in upper-limb multiple sclerosis tremor.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 14, p. 1847, doi. 10.1177/1352458515577690
- By:
- Publication type:
- Article
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 3, p. 344, doi. 10.1177/1352458510389101
- By:
- Publication type:
- Article
Lesion Volume in Relapsing Multiple Sclerosis is Associated with Perivascular Space Enlargement at the Level of the Basal Ganglia.
- Published in:
- American Journal of Neuroradiology, 2022, v. 43, n. 2, p. 238, doi. 10.3174/ajnr.A7398
- By:
- Publication type:
- Article
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 5, p. 581, doi. 10.1007/s00415-006-0315-8
- By:
- Publication type:
- Article
How to diagnose multiple sclerosis and what are the pitfalls.
- Published in:
- Internal Medicine Journal, 2009, v. 39, n. 12, p. 792, doi. 10.1111/j.1445-5994.2009.02081.x
- By:
- Publication type:
- Article
Fluctuations of MS births and UV-light exposure.
- Published in:
- Acta Neurologica Scandinavica, 2013, v. 127, n. 5, p. 301, doi. 10.1111/ane.12007
- By:
- Publication type:
- Article
Speech metrics, general disability, brain imaging and quality of life in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 1, p. 259, doi. 10.1111/ene.14523
- By:
- Publication type:
- Article
Re: Early relapses after the first dose of natalizumab in active multiple sclerosis.
- Published in:
- 2009
- By:
- Publication type:
- Letter